AZD 5363

Pricing Availability   Qty
Description: Potent pan-AKT inhibitor
Alternative Names: Capivasertib
Chemical Name: 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
Purity: ≥98% (HPLC)
Pathways (1)

Biological Activity for AZD 5363

AZD 5363 is a potent pan-AKT inhibitor (IC50 values are 3, 7 and 7 nM for AKt 1, 2 and 3, respectively). Also inhibits P70S6K, PKA, ROCK2 and ROCK1 (IC50 values are 6, 7, 60 and 470 nM, respectively). Inhibits growth of tumor cell lines in vitro, particularly breast, endometrial, gastric, hematologic and prostate cancers. Inhibits growth of human tumor xenografts in mice. Enhances in vivo antitumor effects of Docetaxel (Cat. No. 4056) and Lapatinib (Cat. No. 6811). Orally bioavailable.

Compound Libraries for AZD 5363

AZD 5363 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. Find out more about compound libraries available from Tocris.

Technical Data for AZD 5363

M. Wt 428.92
Formula C21H25ClN6O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1143532-39-1
PubChem ID 25227436
Smiles NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for AZD 5363

Solvent Max Conc. mg/mL Max Conc. mM
DMSO 42.89 100

Preparing Stock Solutions for AZD 5363

The following data is based on the product molecular weight 428.92. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.33 mL 11.66 mL 23.31 mL
5 mM 0.47 mL 2.33 mL 4.66 mL
10 mM 0.23 mL 1.17 mL 2.33 mL
50 mM 0.05 mL 0.23 mL 0.47 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

References for AZD 5363

References are publications that support the biological activity of the product.

Davies et al (2012) Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background. Mol.Cancer Ther. 11 873 PMID: 22294718

If you know of a relevant reference for AZD 5363, please let us know.

View Related Products by Product Action

View all Akt (Protein Kinase B) Inhibitors

Keywords: AZD 5363, AZD 5363 supplier, AZD5363, pan, AKT, inhibitors, inhibits, potent, orally, bioavailable, protein, kinase, B, PKB, Capivasertib, Akt, (Protein, Kinase, B), 6978, Tocris Bioscience

Citations for AZD 5363

Citations are publications that use Tocris products.

Currently there are no citations for AZD 5363. Do you know of a great paper that uses AZD 5363 from Tocris? Please let us know.

Reviews for AZD 5363

There are currently no reviews for this product. Be the first to review AZD 5363 and earn rewards!

Have you used AZD 5363?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Pathways for AZD 5363

Akt Signaling Pathway

Akt Signaling Pathway

The Akt signaling pathway plays a key role in the mediation of protein synthesis, metabolism, proliferation and cell cycle progression. It may be referred to as a 'prosurvival' pathway.